Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Target Discovery
How DEL Screening is Used in Living Cells
Living cells create a more relevant physiological environment for DEL screening, says Dr Iolanda Micco, Associate Director of Chemistry & Alliances at Vipergen
Molecular Drug Design
Interview with Martin Fergie, Lecturer in Health Sciences at the University of Manchester
Martin Fergie, Lecturer in Health Sciences at the University of Manchester, discusses the challenges and future opportunities of AI and ML for bioinformatics.
Target Discovery
First Paediatric Patients Enrolled in Phase III Clinical Trial for Rare Genetic Disease
A clinical trial for the drug leniolisib will go ahead in studying paediatric patients with the rare genetic disease ADPS.
Organ Modelling
Organoids: Opening New Doors for Cancer Research
Organoids are three-dimensional tissue cultures grown from stem cells. They have been among the most important and exciting developments in medical sciences in the last decade.
Navigating the Pharma R&D Regulatory Landscape 2023
Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Molecular Drug Design
Interview with Thierry Dorval, Head of Data Sciences & Data Management at Servier
Thierry Dorval from Servier talks about AI methods, their limitations, and how they are changing the way that data is viewed in the pharmaceutical industry.
Molecular Drug Design
Using Breakthrough Computational Tools for Drug Design and Discovery: AI/ML and Quantum Computing
How quantum annealers, which use quantum mechanics to solve optimisation problems by finding the lowest energy state of a system, are being used for drug discovery.
Chemical Biology
Interview with Felix Hausch, Professor for Structure Based Drug Research at TU Darmstadt
Felix will deliver his presentation 'Clues for Molecular Glues' at Drug Discovery Europe 2023.
Molecular Drug Design
Using ML with DEL: Philogen and Google Partner in New Study
The partnership has developed a new machine learning assisted-technique for DEL screening.
Interview with Nicolas Vachicouras, CEO, Neurosoft Bioelectronics: Subdural Brain Interfaces
Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.